Urinary tract obstruction treatment devices market seen growing to $1.87 billion by 2030

The global market for urinary tract obstruction treatment devices is projected to rise from $1.4 billion in 2025 to $1.87 billion by 2030, according to The Business Research Company. Growth is tied to rising kidney disease, kidney stones, BPH and wider use of minimally invasive urology treatments.

Why it matters: - Urinary tract obstruction treatment devices help restore urine flow, reduce pressure on the kidneys and bladder, and prevent further organ damage. - The market is expanding as more patients need interventions for kidney disease, kidney stones and benign prostatic hyperplasia. - The report points to a growing shift toward minimally invasive and outpatient urology care, which can shorten recovery time and hospital stays.

What happened: - The Business Research Company published its Urinary Tract Obstruction Treatment Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on Sept. 2, 2026. - The report estimates the market at $1.4 billion in 2025 and projects $1.48 billion in 2026. - The market is forecast to reach $1.87 billion by 2030, reflecting a 6.0% CAGR over the forecast period. - North America held the largest share of the market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

The details: - The market’s recent growth is linked to more kidney stones, an aging population, higher rates of BPH, expansion of hospital urology services and more catheterization procedures. - Future growth is expected to come from laser-based urology techniques, outpatient obstruction treatments, improved stent biomaterials, robotic-assisted urology surgeries and efforts to reduce hospital stays. - Key trends cited in the report include minimally invasive management, better laser lithotripsy systems, improved ureteral stent designs, advanced endoscopic stone removal methods and faster post-procedure recovery. - Urinary tract obstruction treatment devices are designed to remove or bypass blockages between the kidneys and bladder, support drainage and aid tissue healing. - The report says rising kidney disease is a primary growth driver because progression can increase urinary tract obstructions and the need to protect kidney function. - Kidney Research UK said in a June 2023 report that about 7.2 million people in the UK live with chronic kidney disease, more than 10% of the population. - Kidney Research UK estimated that 3.25 million of those patients are in advanced stages and 3.9 million are in early stages. - Kidney Research UK projected the UK total will rise to 7.61 million by 2033. - The report’s package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - The company also offers a free sample of the report and the full report at the sample report and the full market report.

Between the lines: - The forecast suggests steady, not explosive, growth, with demand supported by chronic disease trends rather than a single product breakthrough. - The emphasis on outpatient care and robotic-assisted surgery points to continued pressure on hospitals to reduce procedure time and patient recovery time. - The regional snapshot shows North America as the current leader, but the broad geographic coverage signals that future gains may come from multiple markets.

What's next: - The report expects further adoption of less invasive urology tools and improved device materials through 2030. - Market growth will likely track the pace of kidney disease, stone disease and BPH diagnoses, along with how quickly health systems move procedures out of inpatient settings. - The company lists contact details and social channels for follow-up, including LinkedIn, Facebook and X.